These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

334 related articles for article (PubMed ID: 27510172)

  • 1. How FSH and AMH reflect probabilities of oocyte numbers in poor prognosis patients with small oocyte yields.
    Gleicher N; Darmon SK; Kushnir VA; Weghofer A; Wang Q; Zhang L; Albertini DF; Barad DH
    Endocrine; 2016 Nov; 54(2):476-483. PubMed ID: 27510172
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Discordances between follicle stimulating hormone (FSH) and anti-Müllerian hormone (AMH) in female infertility.
    Gleicher N; Weghofer A; Barad DH
    Reprod Biol Endocrinol; 2010 Jun; 8():64. PubMed ID: 20565808
    [TBL] [Abstract][Full Text] [Related]  

  • 3. [Low circulating anti-Müllerian hormone and normal follicle stimulating hormone levels: which prognosis in an IVF program?].
    Grzegorczyk-Martin V; Khrouf M; Bringer-Deutsch S; Mayenga JM; Kulski O; Cohen-Bacrie P; Benaim JL; Belaisch-Allart J
    Gynecol Obstet Fertil; 2012; 40(7-8):411-8. PubMed ID: 22521986
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Discordant anti-müllerian hormone (AMH) and follicle stimulating hormone (FSH) among women undergoing in vitro fertilization (IVF): which one is the better predictor for live birth?
    Wang S; Zhang Y; Mensah V; Huber WJ; Huang YT; Alvero R
    J Ovarian Res; 2018 Jul; 11(1):60. PubMed ID: 30012195
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Predictive value of anti-müllerian hormone, follicle-stimulating hormone and antral follicle count on the outcome of ovarian stimulation in women following GnRH-antagonist protocol for IVF/ET.
    Tsakos E; Tolikas A; Daniilidis A; Asimakopoulos B
    Arch Gynecol Obstet; 2014 Dec; 290(6):1249-53. PubMed ID: 25001569
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Relationship Between Anti-Müllerian Hormone and
    Sun XY; Lan YZ; Liu S; Long XP; Mao XG; Liu L
    Front Endocrinol (Lausanne); 2020; 11():595448. PubMed ID: 33343511
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Anti-Mullerian hormone is a better marker than inhibin B, follicle stimulating hormone, estradiol or antral follicle count in predicting the outcome of in vitro fertilization.
    Kunt C; Ozaksit G; Keskin Kurt R; Cakir Gungor AN; Kanat-Pektas M; Kilic S; Dede A
    Arch Gynecol Obstet; 2011 Jun; 283(6):1415-21. PubMed ID: 21562964
    [TBL] [Abstract][Full Text] [Related]  

  • 8. AMH has no role in predicting oocyte quality in women with advanced age undergoing IVF/ICSI cycles.
    Dai X; Wang Y; Yang H; Gao T; Yu C; Cao F; Xia X; Wu J; Zhou X; Chen L
    Sci Rep; 2020 Nov; 10(1):19750. PubMed ID: 33184364
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Live-birth rates in very poor prognosis patients, who are defined as poor responders under the Bologna criteria, with nonelective single embryo, two-embryo, and three or more embryos transferred.
    Gleicher N; Vega MV; Darmon SK; Weghofer A; Wu YG; Wang Q; Zhang L; Albertini DF; Barad DH; Kushnir VA
    Fertil Steril; 2015 Dec; 104(6):1435-41. PubMed ID: 26348275
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Use of ovarian reserve parameters for predicting live births in women undergoing in vitro fertilization.
    Lukaszuk K; Kunicki M; Liss J; Lukaszuk M; Jakiel G
    Eur J Obstet Gynecol Reprod Biol; 2013 Jun; 168(2):173-7. PubMed ID: 23485092
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Clinical relevance of combined FSH and AMH observations in infertile women.
    Gleicher N; Kim A; Kushnir V; Weghofer A; Shohat-Tal A; Lazzaroni E; Lee HJ; Barad DH
    J Clin Endocrinol Metab; 2013 May; 98(5):2136-45. PubMed ID: 23533225
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Follicle stimulating hormone and anti-Müllerian hormone per oocyte in predicting in vitro fertilization pregnancy in high responders: a cohort study.
    Weghofer A; Kim A; Barad DH; Gleicher N
    PLoS One; 2012; 7(4):e34290. PubMed ID: 22545082
    [TBL] [Abstract][Full Text] [Related]  

  • 13. The use of anti-Müllerian hormone and antral follicle count to predict the potential of oocytes and embryos.
    Majumder K; Gelbaya TA; Laing I; Nardo LG
    Eur J Obstet Gynecol Reprod Biol; 2010 Jun; 150(2):166-70. PubMed ID: 20223579
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Toward a better understanding of functional ovarian reserve: AMH (AMHo) and FSH (FSHo) hormone ratios per retrieved oocyte.
    Gleicher N; Kim A; Weghofer A; Barad DH
    J Clin Endocrinol Metab; 2012 Mar; 97(3):995-1004. PubMed ID: 22170712
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Definition by FSH, AMH and embryo numbers of good-, intermediate- and poor-prognosis patients suggests previously unknown IVF outcome-determining factor associated with AMH.
    Gleicher N; Kushnir VA; Sen A; Darmon SK; Weghofer A; Wu YG; Wang Q; Zhang L; Albertini DF; Barad DH
    J Transl Med; 2016 Jun; 14(1):172. PubMed ID: 27286817
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Specific ranges of anti-Mullerian hormone and antral follicle count correlate to provide a prognostic indicator for IVF outcome.
    Keane K; Cruzat VF; Wagle S; Chaudhary N; Newsholme P; Yovich J
    Reprod Biol; 2017 Mar; 17(1):51-59. PubMed ID: 28132758
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Antimüllerian hormone in gonadotropin releasing-hormone antagonist cycles: prediction of ovarian response and cumulative treatment outcome in good-prognosis patients.
    Arce JC; La Marca A; Mirner Klein B; Nyboe Andersen A; Fleming R
    Fertil Steril; 2013 May; 99(6):1644-53. PubMed ID: 23394782
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Utility of age-specific serum anti-Müllerian hormone concentrations.
    Barad DH; Weghofer A; Gleicher N
    Reprod Biomed Online; 2011 Mar; 22(3):284-91. PubMed ID: 21269880
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Assessment of ovarian reserve with anti-Müllerian hormone: a comparison of the predictive value of anti-Müllerian hormone, follicle-stimulating hormone, inhibin B, and age.
    Riggs RM; Duran EH; Baker MW; Kimble TD; Hobeika E; Yin L; Matos-Bodden L; Leader B; Stadtmauer L
    Am J Obstet Gynecol; 2008 Aug; 199(2):202.e1-8. PubMed ID: 18674663
    [TBL] [Abstract][Full Text] [Related]  

  • 20. What number of oocytes is appropriate for defining poor ovarian response?
    Kim SK; Lee JR; Jee BC; Suh CS; Kim SH
    Yonsei Med J; 2015 Mar; 56(2):482-9. PubMed ID: 25683999
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 17.